Barry M Chauser, MD
Radiation Oncology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 3
- Since medical school
- 62 years
- University of Pittsburgh School of Medicine, 1964
Offices
3 locations · Northern California Radiation Therapists and Oncologists Medical Group · 8 clinicians in this group
Hospitals listed: UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chauser’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G12439 · Current
Licensed to practise in California · since 1966 · expires 2027-07-31 · University of Pittsburgh School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$26,739
Medicare paid this office $26,739 for 47 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Radiation treatment management, 5 treatment sessions | 13 | $5,945 | $175 |
| 3d radiation therapy planning | 14 | $3,311 | $195 |
| Design and construction of complex radiation treatment device | 16 | $3,025 | $50 |
| New patient visit (60+ min) | 15 | $2,418 | $161 |
| Calculation of radiation therapy dose | 16 | $2,166 | $26 |
See all 9 services
| Radiation treatment management, 5 treatment sessions | 13 | $5,945 | $175 |
| 3d radiation therapy planning | 14 | $3,311 | $195 |
| Design and construction of complex radiation treatment device | 16 | $3,025 | $50 |
| New patient visit (60+ min) | 15 | $2,418 | $161 |
| Calculation of radiation therapy dose | 16 | $2,166 | $26 |
| Complex radiation therapy planning | 14 | $2,125 | $152 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 12 | $985 | $70 |
| Short return visit (20+ min) | 13 | $785 | $56 |
| Short return visit | 12 | $374 | $27 |
Who their Medicare patients are
47 Original Medicare patients in 2024. Average age 77 · Women 62% · Also on Medicaid 36% · Health risk score 2.35. Sicker patients than 9 in 10 peers; the typical radiation oncology clinician is at 1.69.
Conditions among them: High blood pressure 75% · Cancer 75% · Chronic kidney disease 38% · Diabetes 34% · Coronary heart disease 34%.
The office billed $119,148, Medicare allowed $33,891 and paid $26,739; for 324 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 47 | 324 | 77 | 2.35 | $119,148 | $26,739 |
| 2023 | 42 | 174 | 76 | 1.21 | $68,390 | $15,966 |
| 2022 | 22 | 138 | 77 | 1.54 | $37,910 | $8,888 |
| 2021 | 30 | 267 | 76 | 1.61 | $86,913 | $20,707 |
| 2020 | 37 | 196 | 77 | 2.32 | $59,196 | $14,111 |
| 2019 | 56 | 387 | 77 | 1.67 | $116,695 | $27,122 |
| 2018 | 58 | 349 | 78 | 1.70 | $113,833 | $25,375 |
| 2017 | 58 | 606 | 76 | 1.67 | $222,777 | $47,174 |
| 2016 | 64 | 499 | 75 | 1.62 | $200,439 | $46,156 |
| 2015 | 36 | 371 | 77 | 2.57 | $154,314 | $35,228 |
| 2014 | 62 | 942 | 76 | 2.43 | $307,130 | $69,840 |
| 2013 | 80 | 1,308 | 77 | 1.51 | $432,322 | $94,890 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 14 | $1,137 | $57 |
| Short return visit | 17 | $457 | $27 |
2021: 1 service
| Short return visit (20+ min) | 14 | $851 | $57 |
2020: 1 service
| Short return visit (20+ min) | 17 | $921 | $44 |
2019: 6 services
| Complex radiation therapy planning | 15 | $2,264 | $151 |
| Design and construction of complex radiation treatment device | 12 | $1,815 | $55 |
| Short return visit (20+ min) | 20 | $1,313 | $45 |
| New patient visit (30+ min) | 18 | $1,204 | $67 |
| Calculation of radiation therapy dose | 12 | $742 | $30 |
| Short return visit | 12 | $270 | $21 |
2018: 3 services
| Radiation treatment management, 5 treatment sessions | 15 | $10,473 | $164 |
| Short return visit (20+ min) | 11 | $478 | $43 |
| Short return visit | 15 | $328 | $22 |
2017: 7 services
| Radiation treatment management, 5 treatment sessions | 31 | $19,186 | $155 |
| Design and construction of complex radiation treatment device | 25 | $5,034 | $50 |
| Complex radiation therapy planning | 26 | $3,741 | $139 |
| 3d radiation therapy planning | 17 | $3,374 | $187 |
| Calculation of radiation therapy dose | 25 | $1,123 | $27 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 15 | $1,096 | $69 |
| New patient visit (30+ min) | 15 | $944 | $63 |
2016: 8 services
| Radiation treatment management, 5 treatment sessions | 26 | $17,771 | $168 |
| Design and construction of complex radiation treatment device | 27 | $5,293 | $58 |
| 3d radiation therapy planning | 18 | $4,221 | $201 |
| Complex radiation therapy planning | 25 | $4,002 | $148 |
| New patient visit (60+ min) | 13 | $1,948 | $150 |
| New patient visit (30+ min) | 28 | $1,839 | $66 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 20 | $1,690 | $73 |
| Calculation of radiation therapy dose | 30 | $1,516 | $29 |
2015: 7 services
| Radiation treatment management, 5 treatment sessions | 26 | $13,490 | $165 |
| Design and construction of complex radiation treatment device | 27 | $5,345 | $57 |
| Complex radiation therapy planning | 26 | $3,743 | $144 |
| Complex radiation therapy planning for delivery of external radiation | 20 | $3,063 | $133 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 26 | $1,860 | $72 |
| New patient visit (30+ min) | 13 | $768 | $59 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 11 | $416 | $32 |
2014: 11 services
| Radiation treatment management, 5 treatment sessions | 40 | $26,621 | $165 |
| Design and construction of complex radiation treatment device | 41 | $10,651 | $57 |
| Complex radiation therapy planning | 37 | $5,856 | $146 |
| Calculation of radiation therapy dose | 42 | $5,428 | $28 |
| Isodose radiation therapy plan, complex | 40 | $4,042 | $72 |
| New patient visit (60+ min) | 20 | $2,994 | $150 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 37 | $2,959 | $72 |
| Ct guidance for insertion of radiation therapy fields | 34 | $1,490 | $39 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,072 | $89 |
| New patient visit (30+ min) | 11 | $743 | $68 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 21 | $710 | $31 |
2013: 10 services
| Radiation treatment management, 5 treatment sessions | 50 | $36,133 | $158 |
| Design and construction of complex radiation treatment device | 51 | $11,489 | $54 |
| Complex radiation therapy planning | 54 | $7,967 | $140 |
| Calculation of radiation therapy dose | 54 | $6,703 | $27 |
| New patient visit (60+ min) | 44 | $6,388 | $145 |
| Isodose radiation therapy plan, complex | 43 | $4,323 | $69 |
| Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | 52 | $3,773 | $69 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,515 | $176 |
| Ct guidance for insertion of radiation therapy fields | 48 | $1,976 | $37 |
| Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | 27 | $920 | $31 |
Drugs they prescribed that Part D paid
$1,614
Pharmacies billed $1,614 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 52) in 2024. At or below the middle of the specialty; the typical radiation oncology clinician is at 11%.
44 generic and fewer than 11 brand-name prescriptions · $1,614 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 52 | None | 0% (0) | None | $1,614 |
| 2023 | 51 | 16 | 0% (0) | 27% | $672 |
| 2022 | 57 | 15 | 0% (0) | None | $982 |
| 2021 | 105 | 23 | None | 28% | $7,599 |
| 2020 | 95 | 19 | 12% (11) | 26% | $2,008 |
| 2019 | 92 | 28 | None | 28% | $1,420 |
| 2018 | 89 | 21 | None | 24% | $2,156 |
| 2017 | 165 | 40 | None | None | $6,058 |
| 2016 | 180 | 40 | 7% (12) | 16% | $4,855 |
| 2015 | 215 | 40 | 9% (20) | None | $14,905 |
| 2014 | 213 | 52 | 16% (35) | 31% | $15,844 |
| 2013 | 249 | 58 | 18% (45) | 19% | $15,647 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Levothyroxine | 12 | $274 | $23 |
2022: 1 drug
| Levothyroxine | 13 | $327 | $25 |
2021: 2 drugs
| Levothyroxine | 20 | $435 | $22 |
| Dexamethasone | 11 | $111 | $10 |
2020: 1 drug
| Levothyroxine | 19 | $432 | $23 |
2019: 1 drug
| Levothyroxine | 21 | $538 | $26 |
2018: 1 drug
| Levothyroxine | 23 | $689 | $30 |
2017: 1 drug
| Levothyroxine | 46 | $1,171 | $25 |
2016: 2 drugs
| Levothyroxine | 36 | $1,220 | $34 |
| Pantoprazole | 12 | $64 | $5 |
2015: 4 drugs
| Tamsulosin | 17 | $1,333 | $78 |
| Levothyroxine | 28 | $871 | $31 |
| Hydrocodone-Acetaminophen | 13 | $237 | $18 |
| Losartan | 11 | $77 | $7 |
2014: 6 drugs
| Femara | 12 | $7,668 | $639 |
| Carafate | 12 | $1,585 | $132 |
| Levothyroxine | 18 | $474 | $26 |
| Diphenoxylate-Atropine | 20 | $447 | $22 |
| Dexamethasone | 11 | $92 | $8 |
| Prednisone | 11 | $60 | $5 |
2013: 7 drugs
| Femara | 12 | $6,664 | $555 |
| Tamsulosin | 19 | $627 | $33 |
| Diphenoxylate-Atropine | 27 | $380 | $14 |
| Levothyroxine | 27 | $290 | $11 |
| Hydrocodone-Acetaminophen | 23 | $272 | $12 |
| Hydromorphone | 11 | $139 | $13 |
| Losartan | 11 | $105 | $10 |
Money from drug and device companies
$67 in 2025
| 2025 | 2 | 2 | None | $67 |
| 2024 | 3 | 3 | None | $73 |
| 2023 | 1 | 1 | None | $99 |
| 2019 | 2 | 5 | None | $63 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Coherus Oncology | Loqtorzi | $37 | 1 payment
|
| Janssen Biotech | Rybrevant | $30 | 1 payment
|
See all 2 published payments
| Janssen Biotech | Meals · 2025-03-17 | Rybrevant | $30 |
| Coherus Oncology | Meals · 2025-01-22 | Loqtorzi | $37 |
See earlier years (2024, 2023, 2019)
2024: $73
| Invivyd | Pemgarda | $31 | 1 payment
|
| Coherus Biosciences | Loqtorzi | $28 | 1 payment
|
| Abbott Laboratories | Alinity | $14 | 1 payment
|
2023: $99
| AstraZeneca Pharmaceuticals LP | Imfinzi | $99 | 1 payment
|
2019: $63
| Merck Sharp & Dohme | Keytruda | $37 | 2 payments
|
| Sirtex Medical | Sir-Spheres Microspheres | $26 | 3 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Bayer HealthCare Pharmaceuticals Inc. · Clinical Trial Pase IV (Post Marketing) (Bayer Product Or Ta) · 2020 | Their institution | $1,000 |
Professional record
- NPI
- 1902897515
- Licence
- CA G12439California G12439: Current · expires 2027-07-31
- Trained
- University of Pittsburgh School of Medicine, 1964 · 62 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 2085R0001X (2085R0001X)
- Mailing address
- 4301 Northstar Way, Modesto, CA, 95356
- NPI first listed
- 2005-11-02
- NPI last updated
- 2008-12-09
This is when the NPI record was last certified, not a medical board exam.